Vnitr Lek 1991, 37(1):63-72

[Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy].

Z Hrncír, P Bradna, H Nozicková, M Tichý
II. interní klinika lékarské fakulty Univerzity Karlovy, Hradec Králové.

Pulsed i.v. treatment with methylprednisolone (MP) infusions à 1 g 3-5 times on alternate days was administered in 22 diffuse connective tissue diseases: 13X systemic lupus erythematosus (SLE), 1X Sharp's syndrome and 8X polymyositis/dermatomyositis (PM/DM). In all instances active disease was involved with serious organ manifestations; 17 patients had no aimed treatment so far, in 5 previous treatment had failed. A total of 101 pulsed MP was administered. Initial MP treatment was always successful. The patients were then followed up during oral maintenance treatment for 3-60 months (mean 27 months) in a stage of persistent, inconstant or partial remission. In six patients treatment was repeated 8X after reactivation. The response was always favourable and did not differ from that to initial MP treatment, except for one female patient who died from progression of PM/DM (one female patient died from the sequels of oncological disease associated with SLE).

Keywords: Adolescent; Adult; Connective Tissue Diseases, drug therapy, ; Dermatomyositis, drug therapy, ; Female; Humans; Lupus Erythematosus, Systemic, drug therapy, ; Male; Methylprednisolone, administration & dosage, ; Middle Aged; Mixed Connective Tissue Disease, drug therapy,

Published: January 1, 1991  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrncír Z, Bradna P, Nozicková H, Tichý M. [Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy]. Vnitr Lek. 1991;37(1):63-72.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.